Related Experiment Videos

Subclinical hypothyroidism is associated with elevated high-sensitive C-reactive protein among adult Taiwanese

Ya-Ting Yu1, Chih-Te Ho, Hua-Shai Hsu

  • 1Department of Family Medicine, China Medical University Hospital, 2, Yuh-Der Road, Taichung, 404, Taiwan.

Endocrine
|March 8, 2013
PubMed

Insights

Subclinical hypothyroidism (SCH) in Taiwanese adults is linked to higher levels of high-sensitivity C-reactive protein (hsCRP), an inflammation marker. This suggests inflammation may connect SCH to cardiovascular disease risk.

Area of Science:

  • Endocrinology
  • Cardiovascular Disease Research
  • Inflammation Biomarkers

Background:

  • Subclinical hypothyroidism (SCH) is associated with increased cardiovascular disease (CVD) risk.
  • High-sensitivity C-reactive protein (hsCRP) is a key inflammatory marker linked to CVD.
  • The role of inflammation as a mediator between SCH and CVD remains unclear.

Purpose of the Study:

  • To investigate the association between subclinical hypothyroidism and hsCRP levels in a Taiwanese population.
  • To explore whether inflammation, indicated by hsCRP, is a mechanistic link between SCH and CVD.

Main Methods:

  • A cohort of 2,494 Taiwanese adults (age >19) was studied from 2006-2008.
  • SCH was defined by TSH levels (5.61-19.9 mIU/L) with normal thyroxine.
  • Logistic and linear regression analyses assessed the relationship between hsCRP quartiles and SCH, adjusting for confounders.

Main Results:

  • Elevated hsCRP quartiles were significantly associated with subclinical hypothyroidism.
  • A dose-response relationship was observed, with higher hsCRP quartiles showing increased odds of SCH.
  • hsCRP levels were positively associated with serum TSH levels, even after adjusting for confounders.

Conclusions:

  • Adult Taiwanese with subclinical hypothyroidism exhibit higher hsCRP levels.
  • Inflammation, as measured by hsCRP, may play a role in the increased CVD risk associated with SCH.
  • Further research is warranted to elucidate the precise mechanisms linking SCH, inflammation, and cardiovascular outcomes.

Related Concept Videos

Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...